Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2019-04-26
4:45 pm
Sale		13DOncoMed Pharmaceuticals Inc
OMED		BIOTECHNOLOGY VALUE FUND L P0
0%		-4,042,989decrease
(Position Closed)		View
2019-03-15
4:40 pm
Unchanged		13DOncoMed Pharmaceuticals Inc
OMED		BIOTECHNOLOGY VALUE FUND L P4,042,989
10.4%		0
(Unchanged)		View
2019-02-14
4:45 pm
Sale		13GOncoMed Pharmaceuticals Inc
OMED		PERCEPTIVE ADVISORS LLC1,719,111
4.5%		-901,786decrease
(-34.41%)		View
2019-02-14
4:43 pm
Sale		13GOncoMed Pharmaceuticals Inc
OMED		BIOTECHNOLOGY VALUE FUND L P4,042,989
10.5%		-228,300decrease
(-5.34%)		View
2019-02-14
06:58 am
Sale		13GOncoMed Pharmaceuticals Inc
OMED		HarbourVest Partners LLC1,901,106
4.92%		-39,992decrease
(-2.06%)		View
2019-02-13
11:23 am
Sale		13GOncoMed Pharmaceuticals Inc
OMED		Phase4 Partners Ltd0
0%		-1,943,509decrease
(Position Closed)		View
2019-02-12
12:39 pm
Purchase		13GOncoMed Pharmaceuticals Inc
OMED		DELPHI VENTURES VIII LP2,070,542
5.4%		15,000increase
(+0.73%)		View
2019-02-08
3:56 pm
Sale		13GOncoMed Pharmaceuticals Inc
OMED		PRIMECAP MANAGEMENT CO5,506,300
14.25%		-59,300decrease
(-1.07%)		View
2018-12-21
07:00 am
Purchase		13GOncoMed Pharmaceuticals Inc
OMED		HarbourVest Partners LLC1,941,098
5.02%		1,941,098increase
(New Position)		View
2018-12-17
4:16 pm
Purchase		13DOncoMed Pharmaceuticals Inc
OMED		Mereo Biopharma Group plc4,130,907
10.7%		4,130,907increase
(New Position)		View